Literature DB >> 16300735

Transcriptional activity of Pax3 is co-activated by TAZ.

Masao Murakami1, Junji Tominaga, Ryosuke Makita, Yasunobu Uchijima, Yukiko Kurihara, Osamu Nakagawa, Tomoichiro Asano, Hiroki Kurihara.   

Abstract

Pax3 is a transcription factor which functions in embryonic development and human diseases. In a yeast two-hybrid screen with full-length Pax3 as bait, we isolated a clone encoding transcriptional co-activator with PDZ-binding motif (TAZ) from an E10.5 mouse embryo cDNA library. Co-immunoprecipitation and nuclear co-localization of TAZ with Pax3 suggest that their association is functionally relevant. In situ hybridization revealed TAZ and Pax3 expression to partially overlap in the paraxial mesoderm, limb buds, and the neural tube. In C2C12 myoblast cells and NIH3T3 cells, TAZ enhanced the transcriptional activity of Pax3 on artificial and microphthalmia-associated transcription factor promoter-luciferase constructs, suggesting that TAZ can function as a co-activator of Pax3. Functional interaction between Pax3 and TAZ may provide a clue to clarifying the mechanism by which Pax3 serves as a transcriptional activator during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300735     DOI: 10.1016/j.bbrc.2005.10.214

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  44 in total

1.  Regulation and function of the TAZ transcription co-activator.

Authors:  Chenying Liu; Wei Huang; Qunying Lei
Journal:  Int J Biochem Mol Biol       Date:  2011-07-20

2.  TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.

Authors:  Qun-Ying Lei; Heng Zhang; Bin Zhao; Zheng-Yu Zha; Feng Bai; Xin-Hai Pei; Shimin Zhao; Yue Xiong; Kun-Liang Guan
Journal:  Mol Cell Biol       Date:  2008-01-28       Impact factor: 4.272

Review 3.  YAP and the Hippo pathway in pediatric cancer.

Authors:  Atif A Ahmed; Abdalla D Mohamed; Melissa Gener; Weijie Li; Eugenio Taboada
Journal:  Mol Cell Oncol       Date:  2017-02-25

4.  Mutations in TAZ/WWTR1, a co-activator of NKX2.1 and PAX8 are not a frequent cause of thyroid dysgenesis.

Authors:  A M Ferrara; L De Sanctis; G Rossi; S Capuano; G Del Prete; E Zampella; P Gianino; A Corrias; G Fenzi; M Zannini; P E Macchia
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

Review 5.  The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.

Authors:  Bin Zhao; Karen Tumaneng; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2011-08-01       Impact factor: 28.824

6.  Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.

Authors:  Ivette Valencia-Sama; Yulei Zhao; Dulcie Lai; Helena J Janse van Rensburg; Yawei Hao; Xiaolong Yang
Journal:  J Biol Chem       Date:  2015-05-20       Impact factor: 5.157

Review 7.  The Hippo signaling pathway in stem cell biology and cancer.

Authors:  Jung-Soon Mo; Hyun Woo Park; Kun-Liang Guan
Journal:  EMBO Rep       Date:  2014-05-12       Impact factor: 8.807

8.  Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model.

Authors:  Zeyu Yang; Kentaro Nakagawa; Aradhan Sarkar; Junichi Maruyama; Hiroaki Iwasa; Yijun Bao; Mari Ishigami-Yuasa; Shigeru Ito; Hiroyuki Kagechika; Shoji Hata; Hiroshi Nishina; Shinya Abe; Masanobu Kitagawa; Yutaka Hata
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

Review 9.  Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.

Authors:  Jennifer D Kubic; Kacey P Young; Rebecca S Plummer; Anton E Ludvik; Deborah Lang
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

10.  Glis3 is associated with primary cilia and Wwtr1/TAZ and implicated in polycystic kidney disease.

Authors:  Hong Soon Kang; Ju Youn Beak; Yong-Sik Kim; Ronald Herbert; Anton M Jetten
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.